Addimmune In The News
Addimmune is focused on creating long-term value for patients, society and investors by developing and testing a cutting-edge gene therapy to cure HIV. Here you can keep up to date with all that we do.
Follow Us On Social Media
In 2019, #Hispanic & #Latinx people made up 29% of new #HIV diagnoses in the US and dependent areas, according to the CDC. We believe more can be done to reduce #HIVstigma and improve #health outcomes for all people living with #HIV. #NLAAD
The Walk to End #HIV by @WhitmanWalker has been moved to Saturday, December 2nd at Anacostia Park. Aligning with #WorldAIDSday, we’ll be joining the community in fighting #stigma and promoting better patient outcomes for #PLWHA.![]()
![]()
We’re excited to see you there! hubs.li/Q025tCd-0
We were excited to participate in the ROTH MKM Healthcare Opportunities Conference today, and share our vision for #genetherapy and its potential to impact human #health.
We Make Headlines, You Can Help
Stay informed and support our work by following our latest achievements with our promising HIV cure. Connect and share with others who are passionate about our mission.
